Dear Editor

We read with great interest the well-crafted article by Kim et al. [@bib1], which reported that presyncopal symptoms during nitrate-stimulated tilt-testing could be explained by decreased systemic vascular resistance (SVR) rather than reduced cardiac output (CO). The study setup is sound, but being accustomed to this methodology [@bib2], [@bib3], we noticed inaccuracies in Tables 2 and 3. The SVR values appear correct, whereas the systemic vascular resistance index (SVRI) values presented seem incorrect. SVR is calculated as 80^\*^(MAP-CVP)/CO, where MAP is mean arterial pressure and CVP is central venous pressure. The normal values of SVR range from 800 to 1200 dynes s/cm^5^ [@bib4], consistent with the original article [@bib1]. SVRI is calculated as 80\*(MAP-CVP)/CI, where CI is cardiac index [@bib5]; and the formula equals 80\*(MAP-CVP)/(CO/BSA), where BSA is body surface area. This formula may also be presented as SVRI=SVR\*BSA, and the normal values of SVRI range from 1900 to 2400 dynes s m^2^/cm^5^ [@bib2], [@bib3], [@bib5]. Notably, the reported SVRI values in the article by Kim et al. [@bib1] range from 612 to 683 and the units are given as dynes s/cm^5^/m^2^, indicating that the SVR values were divided and not multiplied by BSA. The correct SVRI units should be presented as either dynes s/(cm^5^/m^2^) or dynes s\*m^2^/cm^5^. We estimated that the proper SVRI values in the study conducted by Kim et al. [@bib1] would range from 1900 to 2300 dynes s m^2^/cm^5^. We agree with the general results and conclusions of the article; however, the SVRI results should be recalculated.
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